Natus Medical Incorporated
Natus Medical Incorporated, commonly referred to as Natus, is a leading provider of medical devices and services headquartered in the United States. Founded in 1989, the company has established a strong presence in the neurodiagnostic, newborn care, and hearing screening sectors, serving healthcare professionals across North America and globally. Natus is renowned for its innovative products, including advanced neurodiagnostic systems, neonatal monitoring solutions, and audiology equipment, which are designed to enhance patient care and improve clinical outcomes. The company’s commitment to quality and technological advancement has positioned it as a trusted partner in the medical community. With a focus on delivering exceptional value, Natus has achieved significant milestones, including numerous industry awards and recognitions, solidifying its status as a key player in the medical technology landscape.
DitchCarbon Score
How does Natus Medical Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Natus Medical Incorporated's score of 19 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Natus Medical Incorporated's reported carbon emissions
In 2022, Natus Medical Incorporated reported total carbon emissions of approximately 686,600 kg CO2e, comprising 404,000 kg CO2e from Scope 1 emissions and 282,600 kg CO2e from Scope 2 emissions. This data reflects the company's operational impact on climate change, with no reported Scope 3 emissions. Comparatively, in 2021, the company had significantly higher Scope 1 emissions at 533,000,000 kg CO2e, indicating a substantial reduction in direct emissions in the following year. However, Natus Medical has not set any specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). Natus Medical's emissions data is not cascaded from any parent organisation, indicating that the figures are solely representative of its own operations. The company continues to focus on its environmental impact, although further commitments or strategies for future emissions reductions have not been disclosed.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 533,000,000 | 000,000 |
| Scope 2 | - | 000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Natus Medical Incorporated is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
